- Teaching Notes
- Answer Key
Should Vioxx Be Kept Off the Market?
When chronic pain forces a top student to withdraw from college, biology instructor Dr. Sharpe learns that medications (in this case, Vioxx) may be removed from the market for many reasons, including safety concerns. As the case unfolds, students learn how the FDA balances drug safety against medical needs. As written, the case is appropriate for a non-majors biology course. It could also be adapted for use in a more advanced course in cell biology, pharmacology, or biochemistry, or modified to explore statistical analysis, specific analytical methods used for risk/benefit analysis, or bioethical issues.
|Keywords:||Vioxx; clinical trial; Food and Drug Administration; FDA; drug approval; risk-benefit analysis; pharmaceutical; Merck; "Big Pharma"; bioethics|
|Topical Area:||Ethics, Regulatory issues|
|Educational Level:||Undergraduate lower division, Undergraduate upper division|
|Subject Headings:||Biology (General) Biochemistry Pharmacy / Pharmacology|
|Copyright:||Copyright held by the National Center for Case Study Teaching in Science, University at Buffalo, State University of New York. Please see our usage guidelines, which outline our policy concerning permissible reproduction of this work.|
Case teaching notes are intended to help teachers select and adopt a case. They typically include a summary of the case, teaching objectives, information about the intended audience and how the case may be taught, a case analysis or answer key, and references.
Download Teaching Notes
Answer keys provide answers to the questions posed in a case study. Since these questions are intended to be answered by students and are often graded, answer keys are password-protected and access to them is limited to registered instructors.